International Conference on Stem Cell Therapy for Diabetes (ICSCTD - 26)

This track will explore the latest breakthroughs in stem cell therapies aimed at treating diabetes. Emphasis will be placed on innovative approaches that enhance beta cell regeneration and function.

This session will focus on the application of regenerative medicine techniques in the context of diabetes. Discussions will include cellular therapies, gene editing, and their potential to restore normal glucose metabolism.

This track will delve into various methodologies for beta cell replacement, including the use of stem cells and bioengineering solutions. Participants will examine the efficacy and safety of these approaches through recent clinical findings.

This session will highlight significant preclinical studies that have paved the way for clinical applications of stem cell therapy in diabetes. Researchers will present their findings on animal models and their implications for human therapies.

This track will review ongoing and completed clinical trials investigating stem cell therapies for diabetes. Attendees will gain insights into trial designs, outcomes, and future directions in this rapidly evolving field.

This session will cover various transplantation strategies, including islet transplantation and stem cell-derived beta cell transplants. The focus will be on improving transplant outcomes and addressing challenges such as immune rejection.

This track will examine the role of immune modulation in enhancing the efficacy of stem cell therapies for diabetes. Discussions will include strategies to prevent immune rejection and promote long-term graft survival.

This session will focus on tissue engineering techniques aimed at creating functional pancreatic tissues for diabetes therapy. Researchers will discuss biomaterials, scaffolds, and their integration with stem cell technologies.

This track will explore cutting-edge therapies that leverage stem cell technology and other innovative approaches for diabetes management. Presentations will highlight novel treatment modalities and their clinical implications.

This session will address the challenges and successes in translating stem cell research into clinical practice for diabetes. Participants will discuss the pathways from bench to bedside and the importance of multidisciplinary collaboration.

This track will engage participants in discussions surrounding the ethical implications of stem cell research and therapy for diabetes. Topics will include informed consent, regulatory frameworks, and societal impacts.